ASTRUE MICHAEL J

Director at TRANSKARYOTIC THERAPIES INC · on record since Mar 26, 2004
President & CEO at TRANSKARYOTIC THERAPIES INC · on record since Mar 26, 2004
Director at ARQULE INC · on record since May 22, 2006
Director at TERCICA INC · on record since Jun 16, 2006
Director at CURAGEN CORP · on record since May 4, 2006
Director at VIVUS INC · on record since Jul 29, 2013
INTERIM CEO at INVIVO THERAPEUTICS HOLDINGS CORP. · on record since Jan 13, 2014
Chief Executive Officer at EPIX Pharmaceuticals, Inc. · on record since Sep 22, 2005

Insider trading activity of ASTRUE MICHAEL J

Transactions on record: 18; since Mar 26, 2004

Open-market buys: 7; $243.8K

Open-market sells: 0

Companies traded: 6; last filing Jan 13, 2014

Figures computed from official regulatory filings — .

Companies where ASTRUE MICHAEL J has traded

INVIVO THERAPEUTICS HOLDINGS CORP.1 tx · Jan 13, 2014
VIVUS INC2 tx · $119.6K · Sep 6, 2013
TERCICA INC2 tx · Jun 16, 2006
ARQULE INC9 tx · $124.2K · May 22, 2006
CURAGEN CORP2 tx · $174.5K · May 4, 2006
TRANSKARYOTIC THERAPIES INC2 tx · Mar 28, 2005

Track record of ASTRUE MICHAEL J

Open-market buys: 7

Last buy: Sep 4, 2013

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of ASTRUE MICHAEL J

Co-insiders of ASTRUE MICHAEL J

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
INVIVO THERAPEUTICS HOLDINGS CORP.Listing unverified	Jan 13, 2014	Award	108,848	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
VIVUS INCListing unverified	Sep 6, 2013	Buy	10,000	11.96 USD	$119.6K	conv 74Unusual sizeFirst in 12mo	SEC
VIVUS INCListing unverified	Aug 16, 2013	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TERCICA INCListing unverified	Jun 16, 2006	AwardD (derivative)	11,250	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARQULE INCListing unverified	May 22, 2006	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURAGEN CORPListing unverified	May 4, 2006	AwardD (derivative)	15,000	3.85	$57.8K		SEC
TERCICA INCListing unverified	Aug 18, 2005	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURAGEN CORPListing unverified	Jun 15, 2005	AwardD (derivative)	30,000	3.89 USD	$116.7K		SEC
ARQULE INCListing unverified	May 24, 2005	Buy	900	6.08 USD	$5.5K	conv 72First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	700	6.09 USD	$4.3K	conv 50First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	6,300	6.26 USD	$39.4K	conv 59Unusual size	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	1,700	6.07 USD	$10.3K	conv 72First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	3,200	6.10 USD	$19.5K	conv 71First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	7,200	6.27 USD	$45.1K	conv 73Unusual size	SEC
ARQULE INCListing unverified	May 19, 2005	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARQULE INCListing unverified	Apr 11, 2005	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
TRANSKARYOTIC THERAPIES INCListing unverified	Mar 28, 2005	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TRANSKARYOTIC THERAPIES INCListing unverified	Mar 26, 2004	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
INVIVO THERAPEUTICS HOLDINGS CORP.Listing unverified	Jan 13, 2014	Award	108,848	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
VIVUS INCListing unverified	Sep 6, 2013	Buy	10,000	11.96 USD	$119.6K	conv 74Unusual sizeFirst in 12mo	SEC
VIVUS INCListing unverified	Aug 16, 2013	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TERCICA INCListing unverified	Jun 16, 2006	AwardD (derivative)	11,250	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARQULE INCListing unverified	May 22, 2006	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURAGEN CORPListing unverified	May 4, 2006	AwardD (derivative)	15,000	3.85	$57.8K		SEC
TERCICA INCListing unverified	Aug 18, 2005	AwardD (derivative)	22,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CURAGEN CORPListing unverified	Jun 15, 2005	AwardD (derivative)	30,000	3.89 USD	$116.7K		SEC
ARQULE INCListing unverified	May 24, 2005	Buy	900	6.08 USD	$5.5K	conv 72First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	700	6.09 USD	$4.3K	conv 50First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	6,300	6.26 USD	$39.4K	conv 59Unusual size	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	1,700	6.07 USD	$10.3K	conv 72First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	3,200	6.10 USD	$19.5K	conv 71First in 12mo	SEC
ARQULE INCListing unverified	May 24, 2005	Buy	7,200	6.27 USD	$45.1K	conv 73Unusual size	SEC
ARQULE INCListing unverified	May 19, 2005	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARQULE INCListing unverified	Apr 11, 2005	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
TRANSKARYOTIC THERAPIES INCListing unverified	Mar 28, 2005	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TRANSKARYOTIC THERAPIES INCListing unverified	Mar 26, 2004	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC